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Background: Tick-borne encephalitis (TBE) is found in limited endemic foci in Poland. Lack of diagnosis limits
disease detection in non-endemic provinces.
Methods: In 2009, we enhanced TBE surveillance to confirm the location of endemic foci and inform vaccination
policy. In 105 hospitals located in 11/16 provinces, we identified suspected TBE cases through admission ICD-10
codes indicating aseptic meningo-encephalitis or from specimens tested for TBE. The National Reference Laboratory
confirmed cases at no cost, by testing serum and/or cerebrospinal fluid using ELISA method. We calculated TBE
reported rates as the number of confirmed TBE cases per 100,000 inhabitants. Adjusting to neighbouring districts,
we classified districts as non-endemic (<0.1 cases per 100,000 inhabitants), low endemic (> = 0.1 to <1), moderately
endemic (> = 1 to <5) and highly endemic (> = 5). We compared surveillance data obtained in 2009 with
2004–2008 baseline data.
Results: Among 166,099 admissions, we identified 1,585 suspected TBE cases of which 256 were confirmed.
Physicians reported more suspected cases among patients <40 years old (12 cases per 1,000 admissions) than
among older patients (8 cases per 1,000 admissions). However, patients <40 years of age were confirmed less
frequently (16%), than older patients (35%). Physicians reported more suspected cases in districts classed as
endemic during 2004–2008 (12 cases per 1,000 admissions, 77% tested for TBE) than in districts classed as non-
endemic (7 cases per 1,000 admissions, 59% tested). Of the 38 newly identified endemic districts, 31 were adjacent
to 2004–2008 endemic districts and 7 were isolated.
Conclusions: Enhanced surveillance detected 38 new endemic districts to be considered for TBE vaccination.
However, lack of consistent testing in districts believed to be TBE-free remained an obstacle for mapping
TBE risk. Although the disease affects mostly older adults and the elderly, more attention is given to the
diagnosis of TBE in young patients. Solutions need to be identified to sustain sensitive, acceptable and
affordable TBE surveillance in all districts of Poland. Also, higher attention should be given to the diagnosis
of TBE in the elderly.
Keywords: Tick-borne encephalitis, Surveillance, Endemic foci, Poland* Correspondence: pstefanoff@pzh.gov.pl
1National Institute of Public Health-National Institute of Hygiene, Chocimska
24, 00-791 Warsaw, Poland
Full list of author information is available at the end of the article
© 2013 Stefanoff et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Stefanoff et al. Parasites & Vectors 2013, 6:180 Page 2 of 7
http://www.parasitesandvectors.com/content/6/1/180Background
Tick-borne encephalitis (TBE) is caused by TBE virus
(TBEV). The virus is transmitted to susceptible individ-
uals through tick bites or consumption of unpasteurized
milk from recently infected animals [1]. TBE is restricted
to geographical areas referred to as endemic foci [1,2].
Factors influencing survival of ticks, large mammals and
transmission-competent rodents may explain the distri-
bution of these foci and their changes over time [3,4].
Symptoms of TBE do not differ from other infections of
the central nervous system (CNS). Thus laboratory
confirmation of each suspected case is necessary. Due to
their immature CNS, young children experience less
severe symptoms than adults [1]. Compared with other
age groups, the elderly present atypical symptoms and
suffer from severe outcomes and higher case-fatality
[1,5]. One third of infected adults develop flu-like symp-
toms. Of these, one third progresses to meningo-
encephalitis following a 7-day symptom-free interval
[1,6]. Twenty-six to 46% of infected persons who deve-
lop meningo-encephalitis suffer from post-encephalitic
sequelae [1]. No specific anti-viral therapy has been
developed, but safe and effective vaccines are available
[7]. Primary immunisation consisting of three doses
followed by booster doses administered 3–5 years apart
is sufficient to acquire immunity [7,8]. Documentation
of endemic foci allows development of focused vac-
cination recommendations [9,10]. However, to locate
endemic foci, physicians must be aware of the disease
and refer patients with signs of meningo-encephalitis for
testing.
Poland (2010 population: 38 million) is divided into 16
provinces and 379 districts. TBE surveillance was
implemented in 1970. Physicians notify meningo-
encephalitis cases, including confirmed TBE cases.
Vaccination is recommended for persons occupationally
exposed to forests in endemic districts (i.e. farmers,
foresters, soldiers). However, employers or individuals
have to cover the vaccine cost [9]. The location of en-
demic areas for those recommendations is ascertained
based on TBE reported rates. However, in 2004–2008
availability of serological diagnosis in only 39% of the
country’s hospitals suggested that TBE remained undiag-
nosed in many provinces [11]. Furthermore, seropre-
valence surveys among humans and animals suggested
that TBE endemic foci existed in districts where no
human cases had been reported [12,13].
Between March 2009 and April 2010, we implemented
a pilot project of enhanced surveillance for TBE in
selected Polish provinces. We aimed at describing
patterns of the physician’s diagnosis, including referral
for serological testing. In this paper, we summarize
13 months of enhanced TBE surveillance and assess the
degree to which extension of serological testing todistricts where it was not available led to identification
of new endemic foci in Poland.
Methods
We appointed epidemiologists that were delegated from
the local and provincial health departments as local and
provincial coordinators. Their role was to set up enhanced
surveillance in selected wards admitting patients with
aseptic meningo-encephalitis. Before the initiation of the
project, we organized half-day training conferences for all
project participants. The conferences covered lectures on
tick-borne encephalitis and active surveillance methods.
Case definitions
We defined a suspect TBE case as a patient hospitalized
in a participating ward during the study period whose
admission ICD-10 code indicated aseptic meningo-
encephalitis or whose specimen was sent to the National
Reference Laboratory (NRL) for TBE confirmation. We
defined a confirmed TBE case as a suspected case in
which detection of antibodies in serum (IgM and IgG)
and/or in the cerebrospinal fluid CSF (IgG) confirmed
current TBEV infection.
Population under surveillance
Due to logistical constraints, we selected 11 out of 16
Polish provinces, including some with and without known
endemic foci. First, we defined the upper limit for the
number of hospital wards that could be included conside-
ring the available budget. Second, we added provinces
following approval of provincial chief medical officers, and
included hospital wards identified by a prior survey as
routinely notifying aseptic meningo-encephalitis cases
during the previous 5 years [11]. In these hospitals, we
offered physicians the opportunity to send serum and CSF
specimens from suspected cases for free confirmatory
testing in the NRL. The decision to send samples for test-
ing was made by hospital physicians. Local coordinators
screened hospital registers for suspect cases and reported
them weekly to provincial coordinators. For each suspect
case, local coordinators filled out routine surveillance
forms that included demographic, clinical and epidemio-
logical information assessing possible exposure to ticks at
the site of residence and elsewhere. Provincial coordina-
tors collected weekly lists of suspect cases, the information
on the number of requested tests, and surveillance forms.
They validated and forwarded them to the central coor-
dination team.
Laboratory procedures
Serum specimens were diluted 1:100 and tested for IgM
and IgG anti-TBE antibodies. CSF specimens were
diluted 1:10 and tested for IgG anti-TBE antibodies. We
used an ELISA test (FSME/ESME ELISA IgG/IgM
Table 1 Characteristics of patients (n = 1,585) included as
suspect tick-borne encephalitis cases, Poland, March
2009-April 2010
Characteristic Number of patients %







Sex Male 841 53.1
Female 744 46.9
Residence type Rural 712 45.0
Urban 869 55.0












* Summed cases reported in March-April 2009 and March-April 2010.
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according to the manufacturer’s instructions. Results
were expressed in “Vienna Units” (VE) defined as the
ratio of absorbance (OD) of test specimen to the mean
OD values of cut-off control, multiplied by 10. A specimen
was considered positive if VE >11, negative if <9 and
equivocal if 9 ≥VE ≤11. Equivocal results were not con-
sidered for confirming cases. Specimens shipped to the
laboratory were tested once or twice per week. Due to
cross-reactivity with other flaviviruses pathogenic to
humans, TBE ELISA positive results should by confirmed
by more specific methods (ie., heamagglutination or
neutralization tests) [1,14]. This is not performed routinely
in Poland due to high cost and lack of other neuroinvasive
flaviviral infections detected in humans to date.
Data analysis
Choropleth maps were used to display the geographical
location of TBE endemic districts, taking the Eurostat
NUTS-4 administrative districts [15] as the unit of as-
certainment. We calculated reported rates per 100,000
inhabitants by dividing the number of cases assigned to
the presumed district of exposure by district mid-year
census estimates. To account for uneven population
density and uneven case clustering within the districts,
we smoothed the maps of endemic districts by weighting
reported rates of each district to the rates in adjacent
districts. Using these established reported rates, we clas-
sified districts as non-endemic (< 0.1 cases per 100,000
inhabitants), low endemic (> = 0.1 to < 1), moderately
endemic (> = 1 to < 5) and highly endemic (> = 5). We
assigned urban districts (i.e., boundaries of larger towns)
with the same endemicity status as the surrounding rural
districts.
To assess the performance of enhanced surveillance, we
calculated the proportion of TBE suspect cases, propor-
tion of suspect cases referred for testing and proportion of
positives, stratified by age group and 2004–2008 endemi-
city status of the district of hospital location.
We compared the endemicity status of districts in
2009 (using the data from a routine surveillance system
that included additional cases identified through our
project) with their status in 2004–2008 (using data from
the routine surveillance system alone). We defined new
endemic districts as those classified as non-endemic in
2004–2008, that were classified as endemic in 2009. We
used STATA ver. 10 for data management and statistical
analysis [16].
Human subjects protection
The study used existing surveillance data. The only devia-
tion from routine surveillance procedures was facilitating
serum and CSF specimen testing for TBE at the NRL and
planned storage of leftover specimens in a biobank forfurther investigation of neuroinvasive pathogens. The local
coordinators obtained informed consent from each patient
tested. They returned test results to clinicians imme-
diately. The Ethical Committee of the National Institute of
Public Health – National Institute of Health approved the
enhanced surveillance protocol.
Results
We implemented enhanced surveillance in 146 hospital
wards during a median period of 11.2 months (mean
11.5 months, range: 7.2 to 14.2). Of 166,099 patients
admitted to these wards, 1,585 were suspect cases [mean
age: 35.0 years, 841 of males (53%); Table 1]. Hospital
wards included in enhanced surveillance represented
81% of wards hospitalizing meningo-encephalitis pa-
tients in the 11 provinces and 49% of all wards in
Poland.
Of 1,585 suspect cases reported, physicians referred
1,106 (70%) for testing, including 1,028 serum and 808
CSF specimens. TBEV infection was confirmed in 246
patients, 173 based only on serum antibody detection, 6
based only on CSF antibody detection, and 77 based on
antibody detection in both serum and CSF.
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ted patients <40 years old, of which 70% were tested
(Table 2). For the same period, physicians reported 7
suspect cases per 1,000 admitted patients ≥40 years old,
of which 70% were tested (Table 2). The proportion of
patients that tested positive for TBE increased with age
(Figure 1).
In hospitals located in districts classed as moderately
and highly endemic in 2004–2008, physicians reported
an average of 22 TBE suspected cases per 1000 hospi-
talized patients. Of those, 89% were tested for TBE. In
hospitals located in districts classed as non-endemic and
low endemic in 2004–2008, physicians reported 8
suspected cases per 1000 hospitalizations. Of those 64%
were referred for testing (Table 2).
In 2009, 351 TBE cases were reported in Poland (0.92
per 100,000 inhabitants), 51% more than the annual
median number of 233 cases (average annual reported
rate 0.61) in 2004–2008. The status of 291 districts did
not change between the two periods (Table 3). However,
in 2009 we identified 38 new endemic districts. Of these,
31 were adjacent to known endemic foci in the Northeast
and in the South and seven were isolated foci in the North
and Centre of the country (Figure 2).
Discussion
In 2009, we identified 38 new endemic districts. These
may reflect old endemic districts that were undetected
until 2009. Testing for TBE in patients with signs of
meningo-encephalitis doubled in the entire country in
2009, compared with the annual number of specimens
processed in previous years [11]. Moreover, according to
the 2008 survey of hospitals admitting patients with
meningo-encephalitis [11], districts newly identified as
TBE endemic previously lacked routine diagnosis. OneTable 2 Selected surveillance indicators measured in the obse
hospital units, March 2009-April 2010
Characteristic Admissions
Cases
Endemic status of hospital Non-endemic 89,309 639
Low endemic 61,093 594
Moderately endemic 8,731 135
Highly endemic 6,966 217








TBE tick-borne encephalitis.should not rule out that newly identified foci could also
reflect the spread of TBE risk to new foci. Seven of the
new endemic districts were situated away from previously
known endemic foci, most notably in the Northwest of
the country (Figure 2d). The possible existence of un-
detected TBE foci in these areas is supported by earlier
seroepidemiological investigations [13]. New TBE foci can
emerge, as reported in Sweden, Denmark and Norway
[17-21]. Evidence from other European countries indicates
that foci are extending particularly to the north [1,19,22]
and higher altitudes [1,23]. These changes can be
explained by complex interactions of environmental
factors [3,4,18], changing patterns in climate and human
behaviour, including travel, outdoor activities [18,22] and
socio-economic changes [24,25]. For example, Godfrey
and Randolph found a correlation between the 2009 high
increases in TBE reported rates in Poland, Lithuania and
Latvia and the high background levels of poverty [24].
Compared with endemic districts, referral for diagno-
sis was less common in districts that were non-endemic
or low endemic in 2004–2008. According to the 2008
survey of hospitals admitting patients with meningo-
encephalitis [11], physicians were reluctant to refer
patients for TBE testing mostly due to the cost of sero-
logic testing, considered as not justified by the available
treatment options. However, our enhanced surveillance
ensured availability of cost-free diagnosis in all partici-
pating wards. In addition, physicians in districts highly
endemic in 2004–2008 referred patients with signs of
meningo-encephalitis for testing 7-times more com-
monly than in districts considered non-endemic in
2004–2008. The decreased awareness of physicians in
TBE-free districts may result in an underestimation of
TBE outside known endemic areas. This might still leave
possible endemic districts undetected.rved population, by endemic status hospital region, 146
Suspect TBE cases
Cases/1000 hosp. Tested % Positive % of those tested
7.2 378 59.2 17 4.5
9.7 416 70.0 74 17.8
15.5 117 86.7 32 27.4
31.2 195 89.9 133 68.2
3.9 89 65.4 3 3.4
20.7 254 78.2 34 13.4
23.7 209 68.5 39 18.7
16.3 137 61.7 34 24.8
11.8 143 77.7 49 34.3
7.7 142 73.6 53 37.3
4.6 132 60.0 44 33.3


































Testing positive Testing negative % positive
` 
Figure 1 Number of suspected cases tested and percent positive by age group, Poland, March 2009-April 2010.
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few were positive for TBE. In contrast, older adults,
including the elderly were rarely tested, yet a large
proportion was positive. This may reflect the higher
incidence of all cases of meningo-encephalitis diagnosis
among children and adolescents. On the other hand,
TBE leads to more severe disease in elderly patients, and
is more difficult to diagnose because of atypical symp-
toms. This discrepancy between testing practices and
age-specific risk may lead the Polish surveillance system
to underestimate TBE reported rates.
This investigation had a number of limitations. First,
13-month enhanced surveillance may have been too
short timeframe for reliable documentation of TBE foci.
TBEV may circulate undetected for some time before the
transmission to humans starts to occur, due to favourable
weather conditions or socio-economic changes [24,26].
Therefore, the detection of sporadic cases could result in
ascertainment of least populated districts as low en-
demic. To minimize this phenomenon, we smoothed
maps of endemic districts, as was previously carried out
routinely in Germany [27]. Second, we cannot rule out
the possibility that the appearance of new foci reflected




in 2004-2008 Non endemic
Non endemic 239 201 (84%)
Low endemic 95 14 (15%)
Moderately endemic 17 -
Highly endemic 28 -
All districts 379 215 (57%)
TBE tick-borne encephalitis.concomitant high TBE increase recorded in the Baltic
countries that was triggered by an economic downturn
[24]. In Poland it would be difficult to disentangle the
real increase caused by in-work risk of poverty [24] with
the effect of the unlimited testing offered to physicians
through our enhanced surveillance in many regions
where testing was not carried out. Third, coverage
limited to 49% of hospital wards and lower awareness of
physicians working in non-endemic districts may have
led to geographical differences in surveillance perform-
ance. Thus, absence of evidence of disease in our
project cannot be interpreted as a documentation of
absence of TBE risk in several non-endemic districts,
particularly in those where too few specimens were
tested. Finally, cross-reactivity of serological tests used
to confirm TBE [1,14] could theoretically have captured
meningo-encephalitis cases caused by other flaviviruses.
Thus, if other flavivirus were to be documented in
Poland, laboratory diagnosis of TBE should be extended
to neutralization testing.
Conclusions
In conclusion, our enhanced surveillance enabled detec-
tion of new TBE endemic districts by offering systematicen 2004–2008 and 2009
Change of TBE endemic status in 2009
Low endemic Moderately endemic Highly endemic
36 (15%) 2 (1%) -
50 (53%) 31 (32%) -
3 (18%) 12 (71%) 2 (11%)
- - 28 (100%)












b) Endemic regions '2004-2008 c) Endemic regions '2009 d) New endemic regions




Province selected for active surveillance
Figure 2 Geographical distribution of TBE endemic districts, Poland; a) Provinces selected for active surveillance; b) Endemic districts
classified based on average reported rates during 2004–2008; c) Endemic districts classified based on reported rates recorded during
2009; d) Location of the newly identified endemic districts.
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of Polish hospitals. However, lack of consistent testing in
districts believed to be TBE-free remained an obstacle
for mapping TBE risk. Although the disease is more
severe in older adults and the elderly, more attention is
given to the diagnosis of TBE in young patients. On the
basis of these conclusions, we recommend (1) imple-
mentation of the national immunization policy in newly
identified endemic districts; (2) uniform implementation
of diagnostic procedures in all Polish hospitals and (3)
more attention to diagnosis of TBE in the elderly.
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